Hims & Hers Health shares fell 5.61% to $29.99 in Monday's extended trading after the company reported second-quarter results that missed Wall Street's earnings estimate but exceeded revenue expectations. The company posted a quarterly loss of 37 cents per share, wider than the analyst consensus estimate for a loss of three cents, while revenue rose to $753.21 million from $544.83 million a year earlier and came in above the $699.889 million Street estimate. Hims & Hers also said subscribers grew to nearly 2.9 million, up 19% year over year in the second quarter. Looking ahead, the company raised its fiscal 2026 revenue outlook to a range of $3.1 billion to $3.3 billion, topping the $2.93 billion analyst estimate.